StockWatch
·

BAFNA PHARMACEUTICALS LTD. Q4 FY25 Results

BAFNAPHQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue39.0617.7%
Total Income40.0920.1%
Expenditure36.9914.1%
PBT1.3138.3%
Net Profit1.3138.3%
OPM3.39%8.01pp
NPM3.27%0.43pp
EPS0.5537.5%
View full financials

Informational and educational content only. Not investment advice.